Lipopeptide conjugates comprising sphingolipid and hiv gp41 derived peptides
作者： Avraham Ashkenazi , Yechiel Shai
DOI:
关键词:
摘要: The invention provides conjugates comprising a short isolated peptide coupled to sphingolipid, the sequence derived from HIV-1 gp41. sphingolipid-peptide are suitable for treatment of infections caused by human and non-human retroviruses, especially HIV.
lens.org 参考文章(20)
Dennis C. Liotta, Thomas E. Keane, Alfred H. Merrill, Eva M. Schmelz, Kapil N. Bhalla, Sphingolipid derivatives and their methods of use ,(1999)
Debra M. Eckert, Tara R. Suntoke, Peter S. Kim, Peptide inhibitors of hiv entry ,(2001)
Carl T. Wild, Dani P. Bolognesi, Thomas J. Matthews, Compounds which inhibit HIV replication ,(1993)
Dominique P. Bridon, Martin Robitaille, Nissab Boudjellab, Robert P. Dufresne, Peter G. Milner, Long lasting fusion peptide inhibitors of viral infection ,(2000)
Teymuras Kurzchalia, Marino Zerial, Hans-Joachim Knölker, Tim Friedrichson, Georg Schlechtingen, Kai Simons, Michael Munick, Wolfgang Fröhner, Tobias Braxmeier, Gary Jennings, Cornelia Schroeder, Tripartite conjugates containing a structure interacting with cell membrane rafts and their use ,(2005)
Alfonso R. Gennaro, Joseph P. Remington, Remington's pharmaceutical sciences Published in <b>1975</b> in Easton Pa) by Mack. ,(1985)
Carl T. Wild, Dani Paul Bolognesi, Thomas James Matthews, Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids ,(2003)
Carl T Wild, Dennis M Lambert, Dani P Bolognesi, Stephen R Petteway, Shaen O'lin Barney, Thomas J Matthews, Synthetic peptide inhibitors of HIV transmission ,(1994)
Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Compositions for inhibition of membrane fusion-associated events, including human parainfluenza virus transmission ,(1995)
Shawn Barney, Mohmed K. Anwer, Kelly I. Guthrie, Gene Merutka, Dennis M. Lambert, Hybrid polypeptides with enhanced pharmacokinetic properties ,(1999)